Trial Profile

Definitive Radiochemotherapy With 5-FU / Cisplatin Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer: a Phase II Study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Dec 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
Indications Adenocarcinoma; Oesophageal cancer; Squamous cell cancer
Focus Therapeutic Use

Most Recent Events

01 Sep 2020 Status changed from recruiting to completed, as per results published in the Strahlentherapie und Onkologie
31 Aug 2013 Additional lead trial centre added as reported by European Clinical Trials Database record.
31 Aug 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2010-023427-18).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com